Literature DB >> 33988298

A family with partially penetrant multicentric carpotarsal osteolysis due to gonadal mosaicism: First reported case.

Anu Närhi1, Andrea Fernandes2,3,4, Sanna Toiviainen-Salo5, Jessica Harris6, Aideen McInerney-Leo7, Syndia Lazarus2,4,8, Kristiina Avela1, Emma L Duncan9.   

Abstract

Multicentric carpotarsal osteolysis (MCTO) is an autosomal dominant condition characterized by carpal-tarsal abnormalities; over half of affected individuals also develop renal disease. MCTO is caused by mutations of MAFB; however, there is no clear phenotype-genotype correlation. We describe the first reported family of variable MCTO phenotype due to mosaicism: the proband had classical skeletal features and renal involvement due to focal segmental glomerulosclerosis (FSGS), and the father had profound renal impairment due to FSGS, necessitating kidney transplantation. Mosaicism was first suspected in this family due to unequal allele ratios in the sequencing chromatograph of the initial blood sample of proband's father and confirmed by sequencing DNA extracted from the father's hair, collected from different bodily parts. This case highlights the need for a high index of clinical suspicion to detect low-level parental mosaicism, as well as a potential role for MAFB mutation screening in individuals with isolated FSGS.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  MCTO; focal segmental glomerulosclerosis; mosaicism; multicentric carpotarsal osteolysis; v-maf musculoaponeurotic fibrosarcoma oncogene ortholog B (MAFB)

Mesh:

Substances:

Year:  2021        PMID: 33988298     DOI: 10.1002/ajmg.a.62257

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  1 in total

1.  Multicentric Carpotarsal Osteolysis Syndrome Associated Nephropathy: Novel Variants of MAFB Gene and Literature Review.

Authors:  Stefania Drovandi; Francesca Lugani; Olivia Boyer; Edoardo La Porta; Paolo Giordano; Aurélie Hummel; Bertrand Knebelmann; Joséphine Cornet; Genevieve Baujat; Beata S Lipska-Ziętkiewicz; Gian Marco Ghiggeri; Gianluca Caridi; Andrea Angeletti
Journal:  J Clin Med       Date:  2022-07-29       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.